Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angelina Bania
Observed name:
A. Bania
Institution:
University of Patras
Observed institutions:
University College London Hospitals NHS Foundation Trust,
The University of Texas MD Anderson Cancer Center,
University of Patras
ORCID:
0000-0002-5341-7841
Observed ORCID:
0000-0002-5341-7841
OpenAlex ID:
A5001723172
Artificial intelligence-driven ASPECTS for the detection of early stroke changes in non-contrast CT: a systematic review and meta-analysis
2022
·
Antonis Adamou
, Eleftherios T Beltsios
, et al.
·
Journal of NeuroInterventional Surgery
·
33
The Imprint of Exposome on the Development of Atopic Dermatitis across the Lifespan: A Narrative Review
2023
·
Katerina Grafanaki
, Angelina Bania
, et al.
·
Journal of Clinical Medicine
·
31
PDF
Therapeutic Vitamin D Supplementation Following COVID-19 Diagnosis: Where Do We Stand?—A Systematic Review
2022
·
Angelina Bania
, Konstantinos Pitsikakis
, et al.
·
Journal of Personalized Medicine
·
15
PDF
Nutrition and Diet Patterns as Key Modulators of Metabolic Reprogramming in Melanoma Immunotherapy
2025
·
Katerina Grafanaki
, Alexandros Maniatis
, et al.
·
Journal of Clinical Medicine
·
11
The Role of Glia Telomere Dysfunction in the Pathogenesis of Central Nervous System Diseases
2024
·
Manthia A. Papageorgakopoulou
, Angelina Bania
, et al.
·
Molecular Neurobiology
·
11
PDF
Racial and Ethnic Disparities in European Breast Cancer Clinical Trials
2024
·
Angelina Bania
, Antonis Adamou
, et al.
·
Cancers
·
8
Metastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case report
2021
·
Konstantinos Kapriniotis
, Angelina Bania
, et al.
·
Monaldi Archives for Chest Disease
·
4
PDF
89P Inclusion of racial and ethnic minorities in European breast cancer clinical trials
2023
·
A. Bania
, A. Adamou
, et al.
·
ESMO Open
·
3
PDF
Personalized Nutrition in Melanoma: Optimizing Immunotherapy Through Diet and Metabolism
2025
·
K. Grafanaki
, A. Maniatis
, et al.
·
EJC Skin Cancer
·
1
PDF
60P Impact of eIF6 on BRAF inhibitor resistance and translation dynamics in cutaneous melanoma
2024
·
G.C. Kyriakopoulos
, A. Petropoulou
, et al.
·
ESMO Open
·
1
PDF
A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma
2026
·
George Kyriakopoulos
, Antonia Petropoulou
, et al.
·
FEBS Letters
PDF
Author response for "A context-dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma"
2026
·
George Kyriakopoulos
, Antonia Petropoulou
, et al.
Author response for "A context-dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma"
2026
·
George Kyriakopoulos
, Antonia Petropoulou
, et al.
Non-clear cell renal cell carcinoma: unpacking a messy term.
2025
·
Angelina Bania
, Giannicola Genovese
, et al.
·
PubMed
Functional Roles of eIF6 and eIF3j in Vemurafenib Drug Resistance Mechanisms in Melanoma
2025
·
K. Grafanaki
, A. Petropoulou
, et al.
·
EJC Skin Cancer
Role of eIF6 in Modulating Response to BRAF Inhibitors and Acquired Resistance in Cutaneous Melanoma
2024
·
G. Kyriakopoulos
, A. Petropoulou
, et al.
·
EJC Skin Cancer
PDF
Show more works
View as search
Works count:
16
Citation count:
118
H-index:
6
I10-index:
5
Year
Topic
Type